These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2023995)

  • 1. Increased radiation resistance in transformed and nontransformed cells with elevated ras proto-oncogene expression.
    Samid D; Miller AC; Rimoldi D; Gafner J; Clark EP
    Radiat Res; 1991 May; 126(2):244-50. PubMed ID: 2023995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of transfected recombinant oncogenes increases radiation resistance of clonal hematopoietic and fibroblast cell lines selectively at clinical low dose rate.
    FitzGerald TJ; Henault S; Sakakeeny M; Santucci MA; Pierce JH; Anklesaria P; Kase K; Das I; Greenberger JS
    Radiat Res; 1990 Apr; 122(1):44-52. PubMed ID: 2320725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
    Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
    Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc.
    Wang Y; Iliakis G
    Cancer Res; 1992 Feb; 52(3):508-14. PubMed ID: 1732037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of the v-myc oncogene with H-ras on radioresistance.
    McKenna WG; Weiss MC; Endlich B; Ling CC; Bakanauskas VJ; Kelsten ML; Muschel RJ
    Cancer Res; 1990 Jan; 50(1):97-102. PubMed ID: 2403420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the H-ras oncogene on radiation responses of a rat rhabdomyosarcoma cell line.
    Hermens AF; Bentvelzen PA
    Cancer Res; 1992 Jun; 52(11):3073-82. PubMed ID: 1591720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioresistance induced by oncogenic transformation.
    Ling CC; Endlich B
    Radiat Res; 1989 Nov; 120(2):267-79. PubMed ID: 2694214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS; Cohen JD; Ehrlich LS; Bouck NP
    Exp Cell Res; 1993 Apr; 205(2):232-9. PubMed ID: 8482334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of v-src oncogene activation on radiation sensitivity in drug-sensitive and in multidrug-resistant rat fibroblasts.
    Shimm DS; Miller PR; Lin T; Moulinier PP; Hill AB
    Radiat Res; 1992 Feb; 129(2):149-56. PubMed ID: 1734444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene Expression and Cellular Radiation Resistance: A Modulatory Role for c-myc.
    Chiang CS; Sawyers CL; Mcbride WH
    Mol Diagn; 1998 Mar; 3(1):21-27. PubMed ID: 10096954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras.
    Bristow RG; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
    Oncogene; 1994 Jun; 9(6):1527-36. PubMed ID: 8183546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
    Kivinen L; Pitkänen K; Laiho M
    Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological and morphological characteristics of phenotypic revertants appearing in interferon-treated mouse cells transformed by a human oncogene.
    Samid D; Chang EH; Friedman RM; Schaff Z; Greene JJ
    J Exp Pathol; 1985; 2(3):211-22. PubMed ID: 2431116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of normal homologous cells by a spontaneously activated Ha-ras oncogene.
    Schwartz SA; Shuler CF; Freebeck P
    Cancer Res; 1988 Jun; 48(12):3470-7. PubMed ID: 3285996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of a new class of 'flat' revertants from ras-transformed NIH3T3 cells using cis-4-hydroxy-L-proline.
    Yanagihara K; Ciardiello F; Talbot N; McGeady ML; Cooper H; Benade L; Salomon DS; Bassin RH
    Oncogene; 1990 Aug; 5(8):1179-86. PubMed ID: 2202950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
    Kuo ML; Chou YW; Chau YP; Huang TS
    Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cell-substrate adhesion accompanies conditional reversion to the normal phenotype in ras-oncogene-transformed NIH-3T3 cells.
    Shumaker DK; Sklar MD; Prochownik EV; Varani J
    Exp Cell Res; 1994 Oct; 214(2):440-6. PubMed ID: 7925639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
    Velasco JA; Avila MA; Notario V
    Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.